Incyte Corporation
INCY
$59.61
-$2.50-4.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.53% | 16.32% | 23.81% | 9.34% | 8.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.53% | 16.32% | 23.81% | 9.34% | 8.93% |
| Cost of Revenue | 4.73% | 0.71% | 50.89% | 159.33% | -2.10% |
| Gross Profit | 35.15% | 26.10% | -0.72% | -135.23% | 23.64% |
| SG&A Expenses | 8.50% | 11.00% | 15.48% | 7.76% | -4.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.93% | 8.59% | 37.46% | 102.20% | 1.51% |
| Operating Income | 135.87% | 47.17% | -20.84% | -335.20% | 190.88% |
| Income Before Tax | -0.83% | 15.78% | -33.05% | -240.41% | 355.41% |
| Income Tax Expenses | 14.08% | 61.01% | -19.93% | -25.97% | 120.91% |
| Earnings from Continuing Operations | -6.69% | 0.07% | -37.84% | -318.43% | 681.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.69% | 0.07% | -37.84% | -318.43% | 681.22% |
| EBIT | 135.87% | 47.17% | -20.84% | -335.20% | 190.88% |
| EBITDA | 110.11% | 42.55% | -18.48% | -303.90% | 124.22% |
| EPS Basic | 8.13% | 16.16% | -27.70% | -323.49% | 676.26% |
| Normalized Basic EPS | 110.93% | 47.37% | -13.70% | -279.40% | 112.84% |
| EPS Diluted | 6.67% | 14.32% | -28.95% | -326.67% | 670.81% |
| Normalized Diluted EPS | 108.68% | 45.40% | -14.32% | -281.34% | 112.64% |
| Average Basic Shares Outstanding | -13.71% | -13.86% | -14.03% | -2.27% | 0.68% |
| Average Diluted Shares Outstanding | -12.77% | -12.69% | -13.41% | -3.31% | 0.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |